A Surprisingly Strong Start to 2026
So here's the thing β not too long ago, economists were penciling in a fairly modest 2.0% GDP growth rate for South Korea in 2026. But then the first-quarter numbers came in, and let's just say they caught a lot of people off guard. South Korea's Q1 real GDP grew by 1.7% quarter-on-quarter β nearly double the Bank of Korea's own February forecast of 0.9%. That's not a small miss. That's a signal that something meaningful is happening in the Korean economy.
Now, with the Bank of Korea set to release its revised economic outlook on May 28, a survey of six economic experts conducted by Yonhap News Agency suggests the central bank is likely to raise its full-year GDP growth forecast from 2.0% up to somewhere in the 2.5% to 2.6% range. That would be a significant upward revision, and the story behind it is pretty clear: semiconductors.
The Semiconductor Boom Driving the Upgrade
What's really interesting is that this isn't just a regular chip cycle. Analysts are pointing to something more structural. Jang Min, a senior researcher at the Korea Institute of Finance, noted that unlike previous semiconductor booms, this one is rooted in a fundamental shift in demand β specifically, the explosive growth of AI infrastructure. AI servers and high-bandwidth memory chips are flying off the shelves, and South Korea, home to global memory giants Samsung and SK Hynix, is right in the middle of that wave.
Ahn Jae-gyun, a researcher at Korea Investment & Securities, estimates that semiconductor exports accounted for roughly 35% of South Korea's GDP growth contribution in Q1 alone. And he expects that contribution to grow even larger in the second half of the year as shipment volumes increase. Park Jeong-woo, an economist at Nomura Securities, put it bluntly: given the Q1 numbers and the export momentum, a significant upward revision to the annual growth forecast is basically unavoidable.
The ripple effects are being felt across the economy too β not just in production and trade figures, but also in business investment and South Korea's current account balance, which measures the flow of money in and out of the country. When semiconductor exports boom, that surplus tends to improve markedly.
The Inflation Catch: A Double-Edged Sword
Now, here's where things get a little complicated. The same experts who expect the growth forecast to go up are also warning that the inflation forecast is likely to be revised upward too β from the current 2.2% to somewhere between 2.5% and 2.7%. And that matters, because it puts the Bank of Korea in a tricky spot.
Joo Won, head of research at Hyundai Research Institute, flagged the risk of a sharp spike in oil prices and even the possibility of disruptions in the Strait of Hormuz β a critical shipping lane in the Middle East through which roughly 20% of the world's oil supply passes. If that happens, South Korea, which imports almost all of its energy, would feel the squeeze almost immediately through higher import prices. Add in a weak won against the dollar, and consumer prices could climb faster than anyone currently expects.
Cho Young-moo, head of NH Financial Research, summed up the situation well: the uncertainty around both the Iran situation and the semiconductor cycle means the outlook, while broadly positive, still carries meaningful risks in both directions.
A New Fed Chair, a New Chapter for Korea's Financial Conditions
Zooming out a bit, there's another major development that Korean policymakers are watching closely. Kevin Warsh has officially taken the oath of office as the new Chair of the U.S. Federal Reserve β the American central bank whose decisions ripple across every major economy in the world, Korea very much included.
Warsh, who previously served as a Fed Governor during the 2008 global financial crisis, is known as someone who is not easily labeled. He was critical of the Fed's second round of quantitative easing back in 2011 β a signal that he leans hawkish, meaning he's more cautious about loose monetary policy. But he has also recently expressed the view that AI-driven productivity gains could allow for non-inflationary growth, which is a more optimistic, almost dovish take.
In his inaugural remarks, Warsh emphasized the Fed's dual mandate of price stability and maximum employment, while also stressing independence and a reformist approach to how the Fed operates. That's a pointed message β it signals he won't simply bend to pressure from the Trump administration to cut interest rates quickly. President Trump himself, notably, said at the swearing-in ceremony that he wants Warsh to maintain that independence. Whether the words hold in practice remains to be seen.
What This Means for the Korean Won and Korean Policy
For Korea, the implications of a Warsh-led Fed are real and fairly direct. If U.S. interest rates stay elevated for longer, the dollar tends to stay strong. A strong dollar means a weaker won, which is a mixed bag at best. Yes, a weaker won can help Korean exporters price their goods more competitively overseas. But it also pushes up the cost of importing energy and raw materials β which, as we just discussed, is already a concern β and adds upward pressure on consumer prices at home.
There's also the question of capital flows. When U.S. assets look more attractive because of higher yields, foreign investors can be tempted to pull money out of emerging and mid-sized markets like Korea and park it in dollar-denominated assets instead. That kind of outflow puts additional downward pressure on the won.
Commentators have been urging the Bank of Korea to maintain its own credibility and independence in this environment β resisting any political pressure to cut rates purely for short-term economic stimulus. The argument is straightforward: a central bank that markets trust can defend the currency and manage inflation far more effectively than one seen as beholden to electoral cycles.
Korea's Biotech Sector Watches Washington Too
And speaking of Washington, there's another policy development that Korea's pharmaceutical and biotech industry is keeping a very close eye on. U.S. Congressman John Moolenaar, who chairs the House Select Committee on China, sent a letter on May 21 to Treasury Secretary Scott Bessent urging that biotech and pharmaceutical technology be added to the list of prohibited investment categories under the COINS Act β short for the Comprehensive Outbound Investment National Security Act.
The concern driving this push is striking. In 2020, Chinese biotech companies were involved in essentially zero percent of the world's major drug licensing deals valued above $50 million. By last year, that figure had jumped to 48%. In that same period, total licensing deal value between multinational pharma firms and Chinese biotechs reached around $136 billion. Congressman Moolenaar specifically cited a recent $15 billion deal between Bristol Myers Squibb and Chinese firm Hengrui Pharmaceuticals as the kind of transaction that worries U.S. lawmakers β one that effectively transfers valuable intellectual property to China.
So where does Korea fit in? South Korean biotech companies set a record last year for outbound technology licensing deals, surpassing 20 trillion won in total value. The concern is whether a broader U.S. crackdown on Chinese biotech could indirectly affect Korean companies β though analysts are cautiously optimistic. Heo Hye-min, a researcher at Kiwoom Securities, argued that Korean firms actually stand to benefit, pointing to their long track record of partnerships with global pharmaceutical companies and their reputation for high-quality clinical data β advantages that Chinese firms simply don't have to the same degree. She expects a healthy pipeline of deals with both major pharma companies and emerging biotech firms in the second half of this year.
The Big Picture
Put it all together, and you get a Korean economy that is genuinely performing better than expected, powered by a semiconductor sector that is benefiting from one of the most significant technology shifts in a generation. But that good news comes with real caveats β oil price volatility, currency pressure from a stronger dollar under a new Fed regime, and a global trade environment that is growing more complicated by the week. The Bank of Korea's updated forecast on May 28 will be one of the clearest snapshots yet of just how confident policymakers are that the tailwinds can outlast the headwinds.
This article is based on reports from Ddaily, Seoul Economic Daily, Ajunews.

